856 Participants Needed

Mobile Monitoring for Postoperative Complications

(COSMOS Trial)

DI
LH
Overseen ByLisa Humbert, MBA
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: The Cleveland Clinic
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 2 JurisdictionsThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

The investigators plan to determine whether unblinded continuous ward monitoring with the GE Portrait Mobile Monitoring Solution and nursing alerts reduces vital sign abnormalities in patients recovering from major noncardiac surgery.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment GE Portrait Mobile Monitoring Solution for postoperative complications?

Research shows that mobile health systems, like the GE Portrait Mobile Monitoring Solution, can help manage patients after surgery by allowing them to send images and health data to healthcare providers quickly. This can lead to changes in treatment that avoid unnecessary emergency visits, as seen in a study where 18% of cases had their treatment modified based on the data sent, and 96% of patients were satisfied with the mobile health application.12345

Is mobile monitoring for postoperative complications safe for humans?

The studies reviewed indicate that using mobile health tools, like smartphone photography and mobile apps, for monitoring postoperative conditions is generally safe and well-received by patients. Patients reported high satisfaction, and the technology helped in accurately detecting complications and reducing unnecessary hospital visits.16789

How is the GE Portrait Mobile Monitoring Solution treatment different from other treatments for postoperative complications?

The GE Portrait Mobile Monitoring Solution is unique because it uses mobile technology to continuously monitor patients' vital signs and detect complications in real-time, allowing for early intervention and potentially avoiding unnecessary hospital visits. This approach is different from traditional methods that may rely on less frequent monitoring and in-person check-ups.12101112

Research Team

Daniel I. Sessler, M.D.- Outcomes ...

Daniel Sessler, MD

Principal Investigator

The Cleveland Clinic

Eligibility Criteria

This trial is for adults over 18 who are recovering from major noncardiac surgery that lasted at least 1.5 hours, will stay in the hospital overnight, and had general or neuraxial anesthesia. They should be in a physical condition rated between 1-4 by the American Society of Anesthesiologists.

Inclusion Criteria

Expected to be admitted to one of the wards equipped with the GE Portrait Mobile Monitoring Solution
I am 18 years old or older.
My overall health is good enough for surgery.
See 3 more

Exclusion Criteria

Expected to have telemetry monitoring
Have previously participated in the study
I am under end-of-life care plans like Do Not Resuscitate or hospice.
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Unblinded continuous ward monitoring with the GE Portrait Mobile Monitoring Solution and nursing alerts to reduce vital sign abnormalities during the initial 48 postoperative hours

48 hours
Continuous monitoring during hospital stay

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • GE Portrait Mobile Monitoring Solution
Trial OverviewThe COSMOS Trial is testing if continuous monitoring with GE Portrait Mobile Monitoring Solution and nurse alerts can reduce post-surgery vital sign abnormalities compared to standard care without constant monitoring.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Unblinded monitoringExperimental Treatment1 Intervention
Continuous postoperative vital sign monitoring unblinded to clinicians and investigators.
Group II: Blinded monitoringExperimental Treatment1 Intervention
Continuous postoperative vital sign monitoring blinded to clinicians and investigators.

GE Portrait Mobile Monitoring Solution is already approved in European Union, United States for the following indications:

๐Ÿ‡ช๐Ÿ‡บ
Approved in European Union as Portrait Mobile for:
  • Post-surgical monitoring
  • Critical care monitoring
๐Ÿ‡บ๐Ÿ‡ธ
Approved in United States as Portrait Mobile for:
  • Post-surgical monitoring
  • Critical care monitoring

Find a Clinic Near You

Who Is Running the Clinical Trial?

The Cleveland Clinic

Lead Sponsor

Trials
1,072
Recruited
1,377,000+

Findings from Research

A mobile phone system for postoperative management allowed 49 patients to send images and pulse oximetry readings to healthcare providers, resulting in quicker assessments and modifications to treatment in 18% of cases, which helped avoid unnecessary emergency visits.
Patient satisfaction was very high, with 96% of users reporting complete satisfaction with the care received through the mobile health application, indicating its effectiveness and acceptability for managing postoperative care.
Evaluation of a mobile health system for supporting postoperative patients following day surgery.Pรฉrez, F., Montรณn, E., Nodal, MJ., et al.[2017]
A study involving 65 patients showed that using a mobile app for post-operative monitoring was feasible, with high patient engagement as evidenced by an average of 23.9 logins for breast surgery patients and 19.3 for orthopedic patients over 30 days.
Both patients and surgeons reported high satisfaction with the mobile app, scoring it around 3.9 and 3.7 out of 4, indicating that the app effectively facilitated monitoring and could improve post-operative care efficiency.
Using a mobile app for monitoring post-operative quality of recovery of patients at home: a feasibility study.Semple, JL., Sharpe, S., Murnaghan, ML., et al.[2022]
A systematic review of 45 studies found that using mobile health (mHealth) technology for post-surgery monitoring is associated with significantly fewer emergency department visits (odds ratio 0.42) and readmissions (odds ratio 0.47), indicating improved postoperative recovery.
Patients using mHealth reported accelerated improvements in quality of life after surgery, suggesting that remote monitoring can enhance the effectiveness of postoperative care.
Mobile health technology for remote home monitoring after surgery: a meta-analysis.Dawes, AJ., Lin, AY., Varghese, C., et al.[2021]

References

Evaluation of a mobile health system for supporting postoperative patients following day surgery. [2017]
Using a mobile app for monitoring post-operative quality of recovery of patients at home: a feasibility study. [2022]
Mobile health technology for remote home monitoring after surgery: a meta-analysis. [2021]
Swedish Web Version of the Quality of Recovery Scale Adapted for Patients Undergoing Local Anesthesia and Peripheral Nerve Blockade (SwQoR-LA): Prospective Psychometric Evaluation Study. [2021]
Convergent Validity of Three Methods for Measuring Postoperative Complications. [2018]
Smartphone photography for smart assessment of post-surgical wounds - an experience during the COVID-19 pandemic. [2022]
Evaluation of safety, effectiveness and reproducibility of telemedicine for neurosurgical screening. [2020]
Engaging Patients in Co-Design of Mobile Health Tools for Surgical Site Infection Surveillance: Implications for Research and Implementation. [2020]
Identification of Important Features in Mobile Health Applications for Surgical Site Infection Surveillance. [2020]
10.United Statespubmed.ncbi.nlm.nih.gov
Postoperative real-time electrocardiography monitoring detects myocardial ischemia: a case report. [2017]
Use of mobile health technologies for postoperative care in paediatric surgery: A systematic review. [2022]
12.United Statespubmed.ncbi.nlm.nih.gov
Mobile phone-based telemedicine system for the home follow-up of patients undergoing ambulatory surgery. [2022]